Cargando…

Integrative metabolomics differentiate coronary artery disease, peripheral artery disease, and venous thromboembolism risks

RATIONALE: Arterial and venous cardiovascular conditions, such as coronary artery disease (CAD), peripheral artery disease (PAD), and venous thromboembolism (VTE), are genetically correlated. Interrogating distinct and overlapping mechanisms may shed new light on disease mechanisms. OBJECTIVE: In th...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Jiwoo, Gilliland, Thomas, Koyama, Satoshi, Nakao, Tetsushi, Dron, Jacqueline, Lannery, Kim, Wong, Megan, Peloso, Gina M., Hornsby, Whitney, Natarajan, Pradeep
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cold Spring Harbor Laboratory 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10327201/
https://www.ncbi.nlm.nih.gov/pubmed/37425786
http://dx.doi.org/10.1101/2023.06.21.23291103
_version_ 1785069575853834240
author Lee, Jiwoo
Gilliland, Thomas
Koyama, Satoshi
Nakao, Tetsushi
Dron, Jacqueline
Lannery, Kim
Wong, Megan
Peloso, Gina M.
Hornsby, Whitney
Natarajan, Pradeep
author_facet Lee, Jiwoo
Gilliland, Thomas
Koyama, Satoshi
Nakao, Tetsushi
Dron, Jacqueline
Lannery, Kim
Wong, Megan
Peloso, Gina M.
Hornsby, Whitney
Natarajan, Pradeep
author_sort Lee, Jiwoo
collection PubMed
description RATIONALE: Arterial and venous cardiovascular conditions, such as coronary artery disease (CAD), peripheral artery disease (PAD), and venous thromboembolism (VTE), are genetically correlated. Interrogating distinct and overlapping mechanisms may shed new light on disease mechanisms. OBJECTIVE: In this study, we aimed to: identify and compare (1) epidemiologic and (2) causal, genetic relationships between metabolites and CAD, PAD, and VTE. METHODS: We used metabolomic data from 95,402 individuals in the UK Biobank, excluding individuals with prevalent cardiovascular disease. Logistic regression models adjusted for age, sex, genotyping array, first five principal components of ancestry, and statin use estimated the epidemiologic associations of 249 metabolites with incident CAD, PAD, or VTE. Bidirectional two-sample Mendelian randomization (MR) estimated the causal effects between metabolites and cardiovascular phenotypes using genome-wide association summary statistics for metabolites (N = 118,466 from UK Biobank), CAD (N = 184,305 from CARDIoGRAMplusC4D 2015), PAD (N = 243,060 from Million Veterans Project) and VTE (N = 650,119 from Million Veterans Project). Multivariable MR (MVMR) was performed in subsequent analyses. RESULTS: We found that 194, 111, and 69 metabolites were epidemiologically associated (P < 0.001) with CAD, PAD, and VTE, respectively. Metabolomic profiles exhibited variable similarity between disease pairs: CAD and PAD (N = 100 shared associations, R(2) = 0.499), CAD and VTE (N = 68, R(2) = 0.455), and PAD and VTE (N = 54, R(2) = 0.752). MR revealed 28 metabolites that increased risk for both CAD and PAD and 2 metabolites that increased risk for CAD but decreased risk for VTE. Despite strong epidemiologic overlap, no metabolites had a shared genetic relationship between PAD and VTE. MVMR revealed several metabolites with shared causal effects on CAD and PAD related to cholesterol content within very-low-density lipoprotein particles. CONCLUSIONS: While common arterial and venous conditions are associated with overlapping metabolomic profiles, MR prioritized the role of remnant cholesterol in arterial diseases but not venous thrombosis.
format Online
Article
Text
id pubmed-10327201
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Cold Spring Harbor Laboratory
record_format MEDLINE/PubMed
spelling pubmed-103272012023-07-08 Integrative metabolomics differentiate coronary artery disease, peripheral artery disease, and venous thromboembolism risks Lee, Jiwoo Gilliland, Thomas Koyama, Satoshi Nakao, Tetsushi Dron, Jacqueline Lannery, Kim Wong, Megan Peloso, Gina M. Hornsby, Whitney Natarajan, Pradeep medRxiv Article RATIONALE: Arterial and venous cardiovascular conditions, such as coronary artery disease (CAD), peripheral artery disease (PAD), and venous thromboembolism (VTE), are genetically correlated. Interrogating distinct and overlapping mechanisms may shed new light on disease mechanisms. OBJECTIVE: In this study, we aimed to: identify and compare (1) epidemiologic and (2) causal, genetic relationships between metabolites and CAD, PAD, and VTE. METHODS: We used metabolomic data from 95,402 individuals in the UK Biobank, excluding individuals with prevalent cardiovascular disease. Logistic regression models adjusted for age, sex, genotyping array, first five principal components of ancestry, and statin use estimated the epidemiologic associations of 249 metabolites with incident CAD, PAD, or VTE. Bidirectional two-sample Mendelian randomization (MR) estimated the causal effects between metabolites and cardiovascular phenotypes using genome-wide association summary statistics for metabolites (N = 118,466 from UK Biobank), CAD (N = 184,305 from CARDIoGRAMplusC4D 2015), PAD (N = 243,060 from Million Veterans Project) and VTE (N = 650,119 from Million Veterans Project). Multivariable MR (MVMR) was performed in subsequent analyses. RESULTS: We found that 194, 111, and 69 metabolites were epidemiologically associated (P < 0.001) with CAD, PAD, and VTE, respectively. Metabolomic profiles exhibited variable similarity between disease pairs: CAD and PAD (N = 100 shared associations, R(2) = 0.499), CAD and VTE (N = 68, R(2) = 0.455), and PAD and VTE (N = 54, R(2) = 0.752). MR revealed 28 metabolites that increased risk for both CAD and PAD and 2 metabolites that increased risk for CAD but decreased risk for VTE. Despite strong epidemiologic overlap, no metabolites had a shared genetic relationship between PAD and VTE. MVMR revealed several metabolites with shared causal effects on CAD and PAD related to cholesterol content within very-low-density lipoprotein particles. CONCLUSIONS: While common arterial and venous conditions are associated with overlapping metabolomic profiles, MR prioritized the role of remnant cholesterol in arterial diseases but not venous thrombosis. Cold Spring Harbor Laboratory 2023-06-27 /pmc/articles/PMC10327201/ /pubmed/37425786 http://dx.doi.org/10.1101/2023.06.21.23291103 Text en https://creativecommons.org/licenses/by-nc/4.0/This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License (https://creativecommons.org/licenses/by-nc/4.0/) , which allows reusers to distribute, remix, adapt, and build upon the material in any medium or format for noncommercial purposes only, and only so long as attribution is given to the creator.
spellingShingle Article
Lee, Jiwoo
Gilliland, Thomas
Koyama, Satoshi
Nakao, Tetsushi
Dron, Jacqueline
Lannery, Kim
Wong, Megan
Peloso, Gina M.
Hornsby, Whitney
Natarajan, Pradeep
Integrative metabolomics differentiate coronary artery disease, peripheral artery disease, and venous thromboembolism risks
title Integrative metabolomics differentiate coronary artery disease, peripheral artery disease, and venous thromboembolism risks
title_full Integrative metabolomics differentiate coronary artery disease, peripheral artery disease, and venous thromboembolism risks
title_fullStr Integrative metabolomics differentiate coronary artery disease, peripheral artery disease, and venous thromboembolism risks
title_full_unstemmed Integrative metabolomics differentiate coronary artery disease, peripheral artery disease, and venous thromboembolism risks
title_short Integrative metabolomics differentiate coronary artery disease, peripheral artery disease, and venous thromboembolism risks
title_sort integrative metabolomics differentiate coronary artery disease, peripheral artery disease, and venous thromboembolism risks
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10327201/
https://www.ncbi.nlm.nih.gov/pubmed/37425786
http://dx.doi.org/10.1101/2023.06.21.23291103
work_keys_str_mv AT leejiwoo integrativemetabolomicsdifferentiatecoronaryarterydiseaseperipheralarterydiseaseandvenousthromboembolismrisks
AT gillilandthomas integrativemetabolomicsdifferentiatecoronaryarterydiseaseperipheralarterydiseaseandvenousthromboembolismrisks
AT koyamasatoshi integrativemetabolomicsdifferentiatecoronaryarterydiseaseperipheralarterydiseaseandvenousthromboembolismrisks
AT nakaotetsushi integrativemetabolomicsdifferentiatecoronaryarterydiseaseperipheralarterydiseaseandvenousthromboembolismrisks
AT dronjacqueline integrativemetabolomicsdifferentiatecoronaryarterydiseaseperipheralarterydiseaseandvenousthromboembolismrisks
AT lannerykim integrativemetabolomicsdifferentiatecoronaryarterydiseaseperipheralarterydiseaseandvenousthromboembolismrisks
AT wongmegan integrativemetabolomicsdifferentiatecoronaryarterydiseaseperipheralarterydiseaseandvenousthromboembolismrisks
AT pelosoginam integrativemetabolomicsdifferentiatecoronaryarterydiseaseperipheralarterydiseaseandvenousthromboembolismrisks
AT hornsbywhitney integrativemetabolomicsdifferentiatecoronaryarterydiseaseperipheralarterydiseaseandvenousthromboembolismrisks
AT natarajanpradeep integrativemetabolomicsdifferentiatecoronaryarterydiseaseperipheralarterydiseaseandvenousthromboembolismrisks